Breakthrough: Ivermectin inhibits the SARS-CoV-2 spike protein from binding to ACE2 receptors in human tissue

http://

Ivermectin, a common anti-parasite drug, has shown great efficacy in the fight against covid-19. For the first time, medical researchers have documented how ivermectin docks to the SARS-CoV-2 spike receptor-binding domain that is attached to the ACE2 receptor. In this way, ivermectin effectively inhibits viral attachment and replication, assisting a precise antiviral response that can target the SARS-CoV-2 spike protein at its most advantageous cleavage site. The researchers showed how ivermectin interferes with the attachment of the spike protein to the human cell membrane Continue reading

Vitamin D offers significant protection from covid-19, but states won’t dare impose Vitamin D mandates

Public health edicts coming from the state, county and corporate levels have focused strictly on controlling human interaction, with mandates for people to cover their mouth and nose. What if these same authorities decided to empower the people with solutions that halt infection, instead of holding human movement, behavior and breath captive indefinitely? What if the states and counties enacted Vitamin D mandates and encouraged the population to do something for their own immune system to mitigate viral attachment, to limit viral load and to halt viral replication? A new study shows sufficient vitamin D levels lower the positivity rate for covid-19. Continue reading